The immune system remembers. Often this memory, primed by past encounters with threats like bacteria or viruses, is an asset. But when that memory is sparked by internal drivers, like chronic inflammation, it can prove detrimental, ...
Apr 27, 2022
0
274
Your immune system's ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease. These cloned immune cells ...
May 7, 2022
1
271
A team of researchers affiliated with Johns Hopkins University and Memorial Sloan Kettering Cancer Center has found some of the reasons for different responses to anti-PD-1 checkpoint blockade immunotherapy in cancer patients. ...
Researchers from the Wellcome Sanger Institute, the Hudson Institute of Medical Research, Australia, the University of Cambridge and collaborators, have discovered and named two new strains of bacteria in the microbiome of ...
Apr 14, 2022
0
114
Cell cultures and animal studies show that TriSb92, a new molecule developed by the researchers, protects against coronavirus infection for at least eight hours even in cases of high exposure risk. In contrast to vaccine ...
Jan 10, 2022
0
19
Fresh insights into damaging proteins that build up in the brains of people with Alzheimer's disease could aid the quest for treatments.
Dec 10, 2019
0
334
(Medical Xpress)—Among the brain's many functions is the use of predictive models to processing expected stimuli or actions. In such a model, we experience surprise when presented with an unexpected stimulus – that is, ...
Scientists have discovered that the body's own natural killer cells can suppress the immune benefits of therapeutic vaccines, a problem that can affect inoculations against chronic viral infections and cancer.
An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by ...
Jan 28, 2021
2
727
For the first time in the world: a team of researchers from Tel Aviv University and the Israel Institute for Biological Research have developed an mRNA-based vaccine that is 100% effective against a type of bacteria that ...
Mar 9, 2023
0
190
